CervoMed (CRVO) Research & Development (2014 - 2026)
CervoMed (CRVO) posted Research & Development of $4.32 million for Q2 2026, down 15.4% from $5.11 million a year earlier and down 15.8% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Research & Development (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at CervoMed was $21.33 million, down 3.7% year-over-year; for FY2025, it came in at $21.82 million, up 16.1% from FY2024.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- In prior years, CervoMed's Research & Development was $18.8 million in FY2024 (+122.8%), $8.44 million in FY2023 (+531.4%), $1.34 million in FY2022 (-84.3%) and $8.5 million in FY2021 (-9.8%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q2 2024.
- On a year-over-year basis, Research & Development increased in six of the last eight quarters, with growth averaging 54.1%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 650.1%; the weakest was Q3 2022, with a decline of 84.3%.
- According to Business Quant data, Research & Development for the three prior quarters was $5.14 million (Q1 2026), $5.83 million (Q4 2025) and $6.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CervoMed | 27.35 Mn | 27.35 Mn | - | 4.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 6.04 Mn |
| Jun 30, 2025 | 5.11 Mn |
| Mar 31, 2025 | 4.84 Mn |
| Dec 31, 2024 | 7.09 Mn |
| Sep 30, 2024 | 5.13 Mn |
| Jun 30, 2024 | 3.77 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 2.86 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 380,685.00 |
| Sep 30, 2022 | 330,543.00 |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 2.11 Mn |
API Access
CervoMed Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();